Search

Pfizer

Lezárt

SzektorEgészségügy

27.63 0.58

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

27.47

Maximum

27.8

Fő mutatók

By Trading Economics

Bevétel

-2.9B

-238M

Értékesítés

583M

15B

P/E

Szektor átlag

36.474

56.432

Egy részvényre jutó nyereség

0.77

Osztalékhozam

6.2

Profit margin

-1.583

Munkavállalók

75,000

EBITDA

-3.8B

1.2B

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+4.06% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

6.20%

2.27%

Következő eredményjelentés

2026. nov. 3.

Következő korábbi osztalék dátum

2026. nov. 6.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

15B

158B

Előző nyitás

27.05

Előző zárás

27.63

Hangulat hírek alapján

By Acuity

44%

56%

112 / 339 Rangsor szerint Healthcare

Pfizer Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 17. 22:51 UTC

Correlated Moves

Pfizer Inc. is gaining modestly in after-market trading, influenced by fluctuations and the performance of Bristol-Myers Squibb's Phase 3 study results.

2026. szept. 16. 20:10 UTC

News
Social Media

Pfizer Inc faces social media scrutiny over its drug pipeline needs, contributing to a decline despite exceeding revenue and earnings expectations.

2026. szept. 15. 23:02 UTC

Pfizer Inc. shares are roughly flat in after-market trading amid broader market sentiment affected by a decline in the New York Empire State Manufacturing Index.

2026. szept. 14. 23:01 UTC

Pfizer Inc shares are lower in after-market hours, with no specific news identified. Broader market declines are linked to rising crude oil prices.

2026. szept. 11. 23:06 UTC

Pfizer Inc shares are slightly higher in after-market hours, with no specific news identified. The broader market reacted to August's Consumer Price Index data.

2026. szept. 9. 20:07 UTC

News

Pfizer Inc. is gaining during Wednesday's session despite mixed market reactions to its trademark deal with Novartis India, which may impact earnings.

2026. szept. 8. 20:08 UTC

News
Social Media

Pfizer shares are lower as the company announces a webcast featuring CEO Albert Bourla at the Morgan Stanley Healthcare Conference scheduled for September 2026.

2026. szept. 4. 23:05 UTC

Pfizer Inc shares are lower in after-market hours, reflecting a slight decline since Friday's close amid mixed economic signals affecting market sentiment.

2026. szept. 3. 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, following a weak trading session and amid broader market softness from recent economic data on jobless claims.

2026. szept. 2. 23:06 UTC

Pfizer Inc. shares are lower in after-market hours, amid a weaker ADP payrolls report signaling potential labor market weakness affecting future Federal Reserve policy.

2026. szept. 1. 20:09 UTC

News

Pfizer Inc shares reached a 22-month high of $28.86 today, driven by a significant upward trend in the Pharmaceuticals sub-sector amid overall market gains.

2026. aug. 31. 23:06 UTC

Pfizer Inc shares rose in after-hours trading, holding above the 20-day moving average and near the upper end of their one-month range.

2026. aug. 28. 23:01 UTC

Pfizer Inc. shares are lower in after-market trading, continuing a trend from the previous three sessions. No specific news was identified to explain the decline.

2026. aug. 27. 23:02 UTC

Social Media
News

Pfizer and BioNTech received FDA approval for their XFG-adapted COVID-19 vaccine, COMIRNATY XFG, boosting shares in after-market trading.

2026. aug. 26. 23:06 UTC

Pfizer Inc shares are lower in after-market hours amid notable volatility. Broader market weakness and a stronger U.S. Dollar Index contributed to the decline.

2026. aug. 25. 23:06 UTC

Pfizer Inc. shares are lower in after-market trading, reflecting weaker sentiment amid broader market declines linked to falling crude oil prices.

2026. aug. 24. 19:36 UTC

Pfizer Inc. shares are lower today, continuing a decline since Friday's close. The stock remains above its 20-day moving average.

2026. aug. 21. 23:01 UTC

Pfizer Inc shares are lower in after-market trading, reflecting a downward trend amid broader market volatility related to inflation and government debt concerns.

2026. aug. 20. 19:41 UTC

Pfizer Inc's shares are lower today amid a broader downturn in the Pharmaceuticals sub-sector, marking a shift from recent gains.

2026. aug. 19. 23:51 UTC

Pfizer Inc shares are lower in after-market hours, reversing gains from three consecutive sessions. No specific news was identified to explain the price action.

2026. aug. 18. 19:16 UTC

Social Media
Event

Pfizer reported second-quarter adjusted EPS of $0.77, exceeding estimates, and raised its sales outlook for fiscal year 2026, with shares trading higher.

2026. aug. 17. 23:36 UTC

Event

Pfizer Inc shares are lower in after-market hours following the announcement of Xtandi's new indication for prostate cancer treatment. The broader market also declined.

2026. aug. 14. 23:51 UTC

Pfizer Inc. shares are higher in after-market hours amid broader economic concerns following a reported decline in U.S. retail sales for July.

2026. aug. 13. 23:16 UTC

Pfizer Inc shares are lower in after-market hours following a decline from earlier gains. No specific news was identified to explain the movement.

2026. aug. 12. 23:02 UTC

Social Media
News

Pfizer shares rose after Chairman Albert Bourla bought 38,000 shares at $26.34, totaling about $1 million, signaling confidence in the company's prospects.

2026. aug. 11. 19:26 UTC

News

Pfizer Inc. shares are lower amid a $44 million settlement over its Chantix drug, which allegedly contained a cancer-linked substance.

2026. aug. 10. 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, continuing a decline since Monday's close amid rising Treasury yields and inflation concerns.

2026. aug. 8. 00:02 UTC

Pfizer Inc shares are lower in after-market hours with no specific news identified. Broader market concerns about interest rate hikes continue to influence sentiment.

2026. aug. 7. 23:01 UTC

Pfizer Inc shares are lower in after-market hours, reaching a session low earlier. No specific news was identified to explain the decline.

2026. aug. 6. 23:51 UTC

Pfizer Inc shares are lower in after-market hours. The decline follows increased crude oil prices and a strengthening U.S. dollar, contributing to market volatility.

Társak összehasonlítása

Árváltozás

Pfizer Előrejelzés

Célár

By TipRanks

4.06% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 28.574 USD  4.06%

Magas 35.75 USD

Alacsony 25 USD

21 Wall Street elemző 12 hónapos célárain alapulva a(z)Pfizer termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

21 ratings

7

Vétel

13

Tartás

1

Eladás

Hangulat

By Acuity

112 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat